News Conference News PCR London Valves 2024 Sustained Benefit With Pascal TEER Device at 2 Years: CLASP IID and MiCLASP Michael O'Riordan December 05, 2024
News Conference News PCR London Valves 2022 Earlier Interventions and Later Redos? ‘Mature’ TAVI Still Has Growing Pains Shelley Wood November 28, 2022
News Conference News PCR London Valves 2021 Good Results but Small Numbers With JenaValve Trilogy in Severe AR Michael O'Riordan November 26, 2021
News Conference News PCR London Valves 2020 Next-Gen MitraClip Performs as Well as Earlier Device in COAPT: EXPAND Michael O'Riordan November 25, 2020
News Conference News PCR London Valves 2020 CUTTING-EDGE Insights into MV Surgery Outcomes After Failed Clip Procedures Shelley Wood November 24, 2020
News Conference News PCR London Valves 2019 Signal of Impaired Sapien XT Durability in Midterm Follow-up Michael O'Riordan November 20, 2019
News Conference News PCR London Valves 2019 Two Small Series Support Role for Cerebral Protection in TAVR Michael O'Riordan November 18, 2019
News Conference News PCR London Valves 2018 Ten-Year Trends in the UK Show TAVR Rates Rising but SAVR Holding Steady Shelley Wood September 11, 2018
News Conference News PCR London Valves 2016 Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance Shelley Wood September 22, 2016
News Conference News PCR London Valves 2016 TAVR vs SAVR: Limitations and Risks Debated as Transcatheter Therapies Move Into Younger and Lower-Risk Patients Shelley Wood September 20, 2016